The health care business, which makes medical devices and surgical products, has about $1.6 billion in annual sales. The spinoff is expected to be completed at the end of the third quarter of 2014 and is subject to market, regulatory and other conditions. Kimberly-Clark is working with Morgan Stanley on the deal.
Robert Abernathy, who is president of Kimberly-Clark’s Europe group, will become CEO of the new health care company. Abernathy has worked at Dallas-based Kimberly-Clark since 1982.
“While K-C Health Care has been part of our company since the 1970’s, its strategic fit and growth priorities have changed over time and we now think that pursuing a spin-off makes sense for our shareholders,” said Kimberly-Clark CEO and Chairman Thomas Falk.
The health care business is based in Roswell, Ga., and has more than 16,000 employees around the world. Kimberly-Clark operates a tissue- and diaper-manufacturing plant in Beech Island.
Shares of Kimberly-Clark rose $5.79 to $115.50 in after-hours trading Thursday. They were up 87 cents to close at $109.71 during regular trading hours.